Five antigens specific to PCa were selected for the designing of this vaccine [139]: PSA, prostate-specific membrane antigen (PSMA), prostate stem cell antigen (PSCA), six-transmembrane prostate epithelial antigen (STEAP), and prostatic acid phosphatase (PAP) [140]. This evidence concerns the gene FOLH1 and posterior cortical atrophy.